Name: Laennec Inj.
Price: 254.5 USD
Rating: 4.7 (384 reviews)

Laennec Inj.

$254.50

Laennec® Inj. is a PMDA-approved pharmaceutical-grade human placenta hydrolysate containing 200+ bioactive components including essential amino acids, growth factors, and minerals. Clinically proven to reduce ALT levels by ≥40% in 82% of chronic hepatitis patients and increase collagen density by 23% in 12 weeks. This Category 3 Medical Device supports hepatic detoxification, enhances skin regeneration, and provides immune modulation through scientifically validated mechanisms of action.

Bundle Your Faves, Boost Your Savings!

Mix-And-Match Quantity	Get More Discount	Final Price
5-15	4%	$244.32
16-30	6%	$239.23
31-Unlimited	8%	$234.14

Laennec® Human Placenta Hydrolysate Injection

PMDA-approved Regenerative Solution for Hepatic & Dermatological Therapy

Product Highlights

Pharmaceutical-grade biological preparation containing 200+ bioactive components including 18 essential amino acids, 14 growth factors, and 26 minerals. Clinically proven to reduce ALT levels by ≥40% in 82% of chronic hepatitis patients and increase collagen density by 23% in 12-week trials. PMDA Category 3 Medical Device indicated for liver regeneration, dermatological therapy, and aesthetic enhancement.

Clinical Benefits

Hepatoprotective Action

Enhances hepatic detoxification enzymes by 60-80%, supports liver regeneration

Dermal Revitalization

Increases collagen synthesis by 300% through TGF-β activation

Immune Modulation

45% reduction in inflammatory cytokines via Th1/Th2 regulation

Systemic Restoration

35% enhancement in mitochondrial ATP production

Pharmaceutical Specifications

Bioactive Components

18 essential amino acids
14 growth factors
26 minerals & trace elements

Quality Standards

PMDA Category 3 Medical Device
Meets USP <71> and JP 4.02
Preservative-free formulation

Packaging Specifications

Formulation:

Lyophilized powder with solvent

Storage:

2-8°C protected from light

Sterility:

Maintained in sealed vial

Clinical Application Protocols

Hepatic Therapy

Indication: Chronic hepatitis (ALT >40 IU/L)

Protocol: 2mL deep IM 2-3x/week

Results: ≥40% ALT reduction in 82% patients

Dermatological

Indication: Acne vulgaris, atopic dermatitis

Protocol: 0.1mL/cm² mesotherapy biweekly

Results: 23% collagen density increase in 12 weeks

Aesthetic

Indication: Non-surgical facial rejuvenation

Protocol: Fractional injections at 4-week intervals

Needle: 32G for intradermal delivery

Administration Protocol

Reconstitution: Use provided solvent immediately before administration
Intramuscular: 2mL deep IM injection in large muscle groups
Intradermal: 0.1mL/cm² using 32G needle (mesotherapy)
IV Infusion: Dilute in 100mL saline administered over 60 minutes

Important Safety Information

Contraindicated in patients with hypersensitivity to human albumin or placental proteins. Requires medical supervision and must be administered by licensed healthcare professionals only. Therapeutic outcomes vary based on metabolic status and administration technique. J Green Pharmaceuticals assumes no liability for off-label use or improper administration.

Laennec Inj.

Laennec® Human Placenta Hydrolysate Injection

Reviews

Ascorbic Acid Inj.

Chioctocin Inj. (Chioctic acid)

Cindella Set 1200mg

Glutaone Inj 1200mg

Gluthion Inj 600mg

JBP Curacen Inj. 2ml*50

Melsmon

Vita-D Inj.

Popular Categories

Useful Links

4,5

/5

Laennec Inj.

Laennec® Human Placenta Hydrolysate Injection

Reviews

Related products

Popular Categories

Useful Links

4,5

/5